10-K: Better Choice Company Inc. Reports Fiscal Year 2024 Results, Announces Strategic Shift and Pending Merger with SRx Health Solutions

Better Choice Company Inc. reports a net sales decrease of 9% for fiscal year 2024, alongside a strategic shift towards digital channels and a pending merger with SRx Health Solutions.

Summary

• Better Choice Company Inc. reported net sales of $35.0 million for the year ended December 31, 2024, a decrease of 9% compared to $38.6 million in 2023.
• The company experienced a 10% increase in gross profit, reaching $13.0 million in 2024, with a gross profit margin of 37%.
• Operating expenses decreased by 43% to $18.9 million, primarily due to a reduction in selling, general, and administrative expenses.
• The company reported a net loss of $0.2 million for 2024, a significant improvement from the $22.8 million net loss in 2023.
• Digital sales accounted for 47% of net sales in 2024, while international sales contributed 46%.
• The company strategically exited Petco stores and its DTC channel to improve profitability.
• A settlement with Alphia resulted in the forgiveness of a $5.0 million term loan and $0.5 million of PIK accrued interest, and $2.6 million in accounts payable.
• The company entered into an Arrangement Agreement with SRx Health Solutions for an all-stock transaction.

Sentiment

Score: 6

Explanation: The document presents a mixed sentiment. While there are improvements in profitability and cost management, the decrease in net sales and the identification of material weaknesses in internal control over financial reporting raise concerns. The pending merger with SRx Health Solutions adds a positive element, but the overall outlook is cautiously optimistic.

Positives

• Gross profit margin increased to 37% due to improved pricing and product sales mix.
• Operating expenses decreased significantly due to cost-cutting measures.
• Net loss improved substantially, indicating progress towards profitability.
• The settlement with Alphia resulted in the forgiveness of debt and accounts payable.
• The company is pursuing a merger with SRx Health Solutions, which could provide new opportunities for growth.

Negatives

• Net sales decreased by 9% compared to the previous year.
• The company identified material weaknesses in its internal control over financial reporting.
• The company has a history of recurring losses and has an accumulated deficit.

Risks

• The company's ability to continue as a going concern is dependent on generating sufficient cash flow from operations or securing additional financing.
• The company faces risks related to the successful integration of acquisitions and the management of its growth strategy.
• The company is subject to intense competition in the pet health and wellness industry.
• The company's reliance on third-party suppliers and co-manufacturers poses risks to its supply chain.
• The company is subject to extensive governmental regulation and may face enforcement actions for non-compliance.
• The company's level of indebtedness and related covenants could limit its operational and financial flexibility.
• The company's common stock prices may be volatile.

Future Outlook

The company plans to focus on building the Halo brand, capturing fair share online, expanding omnichannel distribution, winning globally, creating fuel for growth through supply chain improvements, and maximizing operating leverage.

Management Comments

• New consumer messaging will build awareness with pet parents, persuade them that Halo is the right choice for their pet, and move the consumer towards purchase.
• By shifting media investment from bottom-of-funnel-driven DTC activities to full funnel activation across the Amazon and Chewy platforms, Halo will see improvements in both media effectiveness, efficiency, and reach.

Industry Context

The pet food market is experiencing moderate growth, with e-commerce continuing to gain market share. Pet owners are increasingly seeking products that improve their pets' health and wellness, and are willing to spend more on pet foods with extra health benefits. Asia, particularly China, represents a significant market opportunity for growth.

Comparison to Industry Standards

• The pet food and treat market in the U.S. is estimated at $54 billion in 2024, with a projected CAGR of 4.4% through 2028, according to Packaged Facts.
• The global plant-based pet food market is projected to reach USD $57.43 billion in 2032, with a CAGR of 9.2%.
• Euromonitor estimates that the Chinese market for premium dry dog and cat food is anticipated to grow at a 20% CAGR and 28% CAGR, respectively, from 2015 through 2025.
• Competitors include major players like Mars, Nestle, and General Mills, as well as specialty brands like Blue Buffalo, Wellness, and Freshpet.

Management Changes

Legal Proceedings

• The company initiated a legal action to enforce a right of first refusal option exercised by Alphia, which was later settled.

Related Party Transactions

• The company entered into an agreement with Believeco to provide marketing support services, where a former member of the Companys board of directors is a partner.

Stakeholder Impact

• The strategic shift towards digital channels and the exit from unprofitable channels may impact suppliers and retail partners.
• The merger with SRx Health Solutions could create new opportunities for employees and shareholders.
• The royalty distribution plan for shareholders may provide a return on investment.

Next Steps

• The company expects to close the sale of its Halo business in Asia in April 2025.
• The company expects to close the acquisition of SRx Health Solutions in 2025.
• The company plans to continue implementing measures to remediate the identified material weaknesses in internal control over financial reporting.

Key Dates

Keywords

pet health, wellness, Halo, SRx Health Solutions, merger, financial results, net sales, gross profit, operating expenses, net loss, Alphia, debt forgiveness, digital sales, international sales, internal control, going concern